NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 54 min 13 sec ago

NIEHS SBIR Phase IIB Validation of Sensors for Improved Environmental Exposure Assessment (R44 Clinical Trial Not Allowed)

Tue, 2020-09-08 03:32
Funding Opportunity RFA-ES-20-016 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports Phase IIB (R44) Small Business Innovative Research (SBIR) grant applications from small businesses concerns (SBCs) to conduct validation studies and accelerate the commercialization of promising environmental health science-related sensor technologies developed in previous Phase II grants or contracts funded by NIH or other federal agencies. The goal of this program is to demonstrate sensor data quality, tool reliability, and usability in real-world conditions in order to transition to more wide-spread adoption and commercialization of these sensor technologies in environmental epidemiology studies, community-based studies, and other public health intervention efforts.

Pre-Application Webinar for RFA-CA-20-040, Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed)

Tue, 2020-09-08 02:59
Notice NOT-CA-20-105 from the NIH Guide for Grants and Contracts

Genomic Data Analysis Network: Genomic Data Center (U24 Clinical Trial Not Allowed)

Fri, 2020-09-04 12:49
Funding Opportunity RFA-CA-20-053 from the NIH Guide for Grants and Contracts. Projects to be Served by Pipeline The proposed analytical network will serve to understand the data generated by CCG programs as well as collaborations with other divisions: The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials (ALCHEMIST) Exceptional Responders (ER, in collaboration with DCTD) Clinical Trials Sequencing Program (CTSP, in collaboration with DCTD) Carcinomas of Unknown Primary (CUPP) Refractory Cancers (Peripheral T-Cell Lymphomas, Recurrent GBMs) This resource that can be utilized by any NCI project that uses the characterization pipeline developed for TCGA and now available as a set of contracts.

NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trial Not Allowed)

Fri, 2020-09-04 12:35
Funding Opportunity RFA-EY-20-001 from the NIH Guide for Grants and Contracts. The National Eye Institute (NEI) intends to advance the Audacious Goals Initiative (AGI) by reissuing a Funding Opportunity Announcement (FOA) to solicit applications using in vivo models for translation-enabling research related to neural regeneration in the visual system.

Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional)

Fri, 2020-09-04 02:24
Funding Opportunity PAR-20-303 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support observational or intervention research focused on reducing disparities in tobacco use and secondhand smoke (SHS) exposure in the U.S. Specifically, this FOA aims to stimulate scientific inquiry focused on innovative state and local level tobacco prevention and control policies. The long-term goal of this FOA is to reduce disparities in tobacco-related cancers, and in doing so, to promote health equity among all populations. Applicants submitting applications related to health economics are encouraged to consult NOT-OD-16-025 to ensure that the research projects align with NIH mission priorities in health economics research.

Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)

Fri, 2020-09-04 02:24
Funding Opportunity PAR-20-302 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support observational or intervention research focused on reducing disparities in tobacco use and secondhand smoke (SHS) exposure in the U.S. Specifically, this FOA aims to stimulate scientific inquiry focused on innovative state and local level tobacco prevention and control policies. The long-term goal of this FOA is to reduce disparities in tobacco-related cancers, and in doing so, to promote health equity among all populations. Applicants submitting applications related to health economics are encouraged to consult NOT-OD-16-025 to ensure that the research projects align with NIH mission priorities in health economics research.

Notice of Special Interest: Advancing the Science of Geriatric Palliative Care

Thu, 2020-09-03 13:41
Notice NOT-AG-20-041 from the NIH Guide for Grants and Contracts

Notice of Intent to Publish Funding Opportunity Announcement to Improve the Nonsurgical Management of Urinary Incontinence in Women

Thu, 2020-09-03 11:59
Notice NOT-HS-20-014 from the NIH Guide for Grants and Contracts

Pre-Application Webinars for RFA-CA-20-047, Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)

Thu, 2020-09-03 10:47
Notice NOT-CA-20-097 from the NIH Guide for Grants and Contracts

HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)

Thu, 2020-09-03 02:50
Funding Opportunity PAR-21-024 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support multi-component, multi-disciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive evaluation of vaccine concepts in non-human primate models may be included.

NIH Blueprint for Neuroscience Research: Functional Neural Circuits of Interoception (R01, Clinical Trial Not Allowed)

Wed, 2020-09-02 12:04
Funding Opportunity RFA-AT-21-003 from the NIH Guide for Grants and Contracts. The NIH Blueprint for Neuroscience Research is a collaborative framework through which 14 NIH Institutes, Centers and Offices jointly support neuroscience related research, with the aim of accelerating discoveries and reducing the burden of nervous system disorders (for further information, see https://neuroscienceblueprint.nih.gov/). The goal of this FOA is to enhance our fundamental understanding of interoception with a specific focus on dissecting neural circuits connecting peripheral organs/tissues with the central nervous system via peripheral ganglia. For this FOA, interoception science includes studies of the processes by which an organism senses, interprets, integrates, and regulates signals originating from within itself. The FOA encourages projects that combine diverse expertise and use innovative approaches to delineate interoceptive mechanisms at the molecular, cellular, circuitry, functional, and/or behavioral levels. Outcomes of this research will lay a critical foundation for future translational and clinical research on interoception as well as its roles in nervous system disorders. Studies of interoceptive neural circuits exclusively within the central nervous system may consider seeking for BRAIN INITIATIVE funding opportunities.

Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)

Wed, 2020-09-02 02:02
Funding Opportunity RFA-ES-20-014 from the NIH Guide for Grants and Contracts. The National Institute of Environmental Health Sciences (NIEHS) is announcing the continuation of the Superfund Hazardous Substance Research and Training Program, referred to as Superfund Research Program (SRP) Centers. SRP Center grants will support problem-based, solution-oriented research Centers that consist of multiple, integrated projects representing both the biomedical and environmental science and engineering disciplines; as well as cores tasked with administrative (which includes research translation), data management and analysis, community engagement, research experience and training coordination, and research support functions. The scope of the SRP Centers is taken directly from the Superfund Amendments and Reauthorization Act of 1986, and includes: (1) advanced techniques for the detection, assessment, and evaluation of the effect on human health of hazardous substances; (2) methods to assess the risks to human health presented by hazardous substances; (3) methods and technologies to detect hazardous substances in the environment; and (4) basic biological, chemical, and physical methods to reduce the amount and toxicity of hazardous substances.

Toward ElucidAting MechanismS Contributing to HIV Reservoirs in NIDDK-relevant Tissues (Cure TEAMS) (R01 Clinical Trial Optional)

Tue, 2020-09-01 12:48
Funding Opportunity RFA-DK-20-023 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support multidisciplinary research teams with complementary expertise in HIV and physiology, pathophysiology, pathobiology, and/or metabolism in organs, tissues, and/or biological systems of specific interest to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). These teams will provide comprehensive mechanistic analyses of the processes leading to the establishment and persistence of latent HIV reservoirs in anatomical sites relevant to the mission of the NIDDK, with the purpose of advancing progress toward developing a cure.

Notice of Special Interest: Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract

Tue, 2020-09-01 05:06
Notice NOT-HD-20-021 from the NIH Guide for Grants and Contracts

Pages